<strong>GLAXOSMITHKLINE</strong><br />Collins Stewart increased its price target for GlaxoSmithKline from 1,360p to 1,383p due to higher long-term forecasts for selected products. It made minor changes to its shorter-term forecasts following a third-quarter performance that was generally in line with forecasts. The broker reiterated its &ldquo;buy&rdquo; recommendation.<br /><br /><strong>TRINITY MIRROR</strong><br />Goldman Sachs downgraded Trinity Mirror from &ldquo;buy&rdquo; to &ldquo;neutral&rdquo; after a period of strong outperformance versus the market. Since the broker added the stock to its conviction &ldquo;buy&rdquo; list, the shares are up 27 per cent, compared to a 9.3 per cent rise in the FTSE World Europe index. Its 186p target price remained unchanged.<br /><br /><strong>ASOS</strong><br />Investec said ASOS is one of its favourite sector players, ahead of the online retailer&rsquo;s interims on 16 November. The broker remains confident in the prospects for longer-term earnings growth, despite a noticeable step-down in domestic sales growth. It has a &ldquo;buy&rdquo; rating on the stock, with a 372p target price.<br /><br />To appear in Best of the Brokers email your research to <strong></strong>